UCLA study: AI model can help predict survival outcomes for patients with cancer

Regulators must step in to safeguard patient data in the AI era

The healthcare sector’s necessary transition towards electronic health records (EHRs) has transformed patient care and operational efficiency.

May 17, 2024

Vol.50 No.20

By Mika Newton

Clinical Roundup

UCLA study: Combination of breast cancer and chemo may speed physical decline in older adults

Women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function, a UCLA-led study suggests.

May 17, 2024

Vol.50 No.20

Drugs & Targets

Leal Health announces next-gen AI patient support platform to enable cancer treatment navigation

Leal Health announced a first-of-its-kind GenAI single point of access technology designed to allow healthcare providers, caregivers, and cancer patients to understand diagnostics and identify personalized treatment options to support the treatment decision process.

May 17, 2024

Vol.50 No.20

Clinical Trials & Tribulations

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

Tumor heterogeneity is a well-recognized hurdle to successful cancer therapy, often leading to resistance and treatment failure.

May 10, 2024

Vol.50 No.19

By Sanju Sinha and Eytan Ruppin

Clinical Roundup

AI-based biomarker stratifies metastasis risk in patients with BCR post-prostatectomy

ArteraAI has validated its first multimodal artificial intelligence digital pathology-based post-radical prostatectomy biomarker for stratifying risk of metastasis and identifying differential absolute benefit for the addition of hormone therapy to salvage radiation therapy in radical prostatectomy patients with biochemical recurrence.

May 10, 2024

Vol.50 No.19

Clinical Roundup

AI tool predicts success of focal therapy for prostate cancer

Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveiled the results of a new UCLA study examining the role of AI in identifying tumor margins and predicting the efficacy of focal therapy treatments.

May 10, 2024

Vol.50 No.19

UCLA study: AI model can help predict survival outcomes for patients with cancer

YOU MAY BE INTERESTED IN

Regulators must step in to safeguard patient data in the AI era

UCLA study: Combination of breast cancer and chemo may speed physical decline in older adults

Leal Health announces next-gen AI patient support platform to enable cancer treatment navigation

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

AI-based biomarker stratifies metastasis risk in patients with BCR post-prostatectomy

AI tool predicts success of focal therapy for prostate cancer

Renew today!

Subscriber content

Login